FRACTYL HEALTH, INC. financial data

Symbol
GUTS on Nasdaq
Location
Burlington, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 285% % -56%
Debt-to-equity 2640% %
Return On Equity -3645% % -1836%
Return On Assets -133% % -171%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137,044,440 shares 185%
Common Stock, Shares, Outstanding 132,216,275 shares 175%
Common Stock, Value, Issued $1,000 USD
Weighted Average Number of Shares Outstanding, Basic 64,652,953 shares 35%
Weighted Average Number of Shares Outstanding, Diluted 64,652,953 shares 35%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $78,324,000 USD 30%
Operating Income (Loss) $98,742,000 USD -21%
Nonoperating Income (Expense) $23,455,000 USD -227%
Net Income (Loss) Attributable to Parent $122,197,000 USD -94%
Earnings Per Share, Basic -2 USD/shares 80%
Earnings Per Share, Diluted -2 USD/shares 80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $77,657,000 USD -8.3%
Assets, Current $79,703,000 USD -9.1%
Property, Plant and Equipment, Net $2,683,000 USD -11%
Operating Lease, Right-of-Use Asset $27,239,000 USD -5.4%
Other Assets, Noncurrent $392,000 USD -88%
Assets $114,272,000 USD -10%
Accounts Payable, Current $1,261,000 USD -29%
Liabilities, Current $18,682,000 USD 19%
Operating Lease, Liability, Noncurrent $26,347,000 USD -4.9%
Other Liabilities, Noncurrent $753,000 USD -30%
Liabilities $117,450,000 USD 53%
Retained Earnings (Accumulated Deficit) $512,537,000 USD -31%
Stockholders' Equity Attributable to Parent $3,178,000 USD -106%
Liabilities and Equity $114,272,000 USD -10%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,079,000 USD -114%
Net Cash Provided by (Used in) Financing Activities $171,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $448,000 USD 58%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 132,216,275 shares 175%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $25,356,000 USD -129%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $81,912,000 USD -7.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,094,000 USD 76%
Depreciation $290,000 USD 447%
Payments to Acquire Property, Plant, and Equipment $448,000 USD -58%
Lessee, Operating Lease, Liability, to be Paid $53,773,000 USD -9.7%
Operating Lease, Liability, Current $5,067,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,817,000 USD -2.7%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,979,000 USD 2.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,735,000 USD -1.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,907,000 USD 3%
Additional Paid in Capital $509,358,000 USD 16%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $7,728,000 USD -40%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%